Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
International Journal of Radiation Biology
|
June 19, 2004
Radiosensitization of tumour cells by cantharidin and some analogues
W A Price, C C Stobbe, S-J Park, et al.
Radiation Research
|
October 1, 1991
The effectiveness of short-term versus long-term exposures to Photofrin II in killing light-activated tumor cells
J D Chapman, C C Stobbe, M R Arnfield, et al.
Radiation Research
|
October 13, 1998
Radiation fields backscattered from material interfaces: I. Biological effectiveness
D L Zellmer, J D Chapman, C C Stobbe, et al.
Radiation Research
|
September 1, 1996
Radiation inactivation of human prostate cancer cells: the role of apoptosis
O Algan, C C Stobbe, A M Helt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 8, 1998
Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
J D Chapman, E L Engelhardt, C C Stobbe, et al.
International Journal of Radiation Biology
|
November 1, 2000
Gold microspheres: a selective technique for producing biologically effective dose enhancement
D M Herold, I J Das, C C Stobbe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 1998
Preclinical assessment of hypoxic marker specificity and sensitivity
R V Iyer, E L Engelhardt, C C Stobbe, et al.
Radiation Research
|
April 1, 1991
Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II
J D Chapman, C C Stobbe, M R Arnfield, et al.
Radiation Research
|
April 6, 1999
Condensed chromatin and cell inactivation by single-hit kinetics
J D Chapman, C C Stobbe, T Gales, et al.
The British Journal of Cancer. Supplement
|
July 1, 1996
Prediction of tumour hypoxia and radioresistance with nuclear medicine markers
J D Chapman, L R Coia, C C Stobbe, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
International Journal of Radiation Biology
|
June 19, 2004
Radiosensitization of tumour cells by cantharidin and some analogues
W A Price, C C Stobbe, S-J Park, et al.
Radiation Research
|
October 1, 1991
The effectiveness of short-term versus long-term exposures to Photofrin II in killing light-activated tumor cells
J D Chapman, C C Stobbe, M R Arnfield, et al.
Radiation Research
|
October 13, 1998
Radiation fields backscattered from material interfaces: I. Biological effectiveness
D L Zellmer, J D Chapman, C C Stobbe, et al.
Radiation Research
|
September 1, 1996
Radiation inactivation of human prostate cancer cells: the role of apoptosis
O Algan, C C Stobbe, A M Helt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 8, 1998
Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
J D Chapman, E L Engelhardt, C C Stobbe, et al.
International Journal of Radiation Biology
|
November 1, 2000
Gold microspheres: a selective technique for producing biologically effective dose enhancement
D M Herold, I J Das, C C Stobbe, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 9, 1998
Preclinical assessment of hypoxic marker specificity and sensitivity
R V Iyer, E L Engelhardt, C C Stobbe, et al.
Radiation Research
|
April 1, 1991
Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II
J D Chapman, C C Stobbe, M R Arnfield, et al.
Radiation Research
|
April 6, 1999
Condensed chromatin and cell inactivation by single-hit kinetics
J D Chapman, C C Stobbe, T Gales, et al.
The British Journal of Cancer. Supplement
|
July 1, 1996
Prediction of tumour hypoxia and radioresistance with nuclear medicine markers
J D Chapman, L R Coia, C C Stobbe, et al.
Page
of 3